Factors Associated with SARS-CoV-2 Infection in Physician Trainees in New York City during the First COVID-19 Wave.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
15 05 2021
Historique:
received: 13 04 2021
revised: 11 05 2021
accepted: 13 05 2021
entrez: 2 6 2021
pubmed: 3 6 2021
medline: 5 6 2021
Statut: epublish

Résumé

Occupational and non-occupational risk factors for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have been reported in healthcare workers (HCWs), but studies evaluating risk factors for infection among physician trainees are lacking. We aimed to identify sociodemographic, occupational, and community risk factors among physician trainees during the first wave of coronavirus disease 2019 (COVID-19) in New York City. In this retrospective study of 328 trainees at the Mount Sinai Health System in New York City, we administered a survey to assess risk factors for SARS-CoV-2 infection between 1 February and 30 June 2020. SARS-CoV-2 infection was determined by self-reported and laboratory-confirmed IgG antibody and reverse transcriptase-polymerase chain reaction test results. We used Bayesian generalized linear mixed effect regression to examine associations between hypothesized risk factors and infection odds. The cumulative incidence of infection was 20.1%. Assignment to medical-surgical units (OR, 2.51; 95% CI, 1.18-5.34), and training in emergency medicine, critical care, and anesthesiology (OR, 2.93; 95% CI, 1.24-6.92) were independently associated with infection. Caring for unfamiliar patient populations was protective (OR, 0.16; 95% CI, 0.03-0.73). Community factors were not statistically significantly associated with infection after adjustment for occupational factors. Our findings may inform tailored infection prevention strategies for physician trainees responding to the COVID-19 pandemic.

Identifiants

pubmed: 34063533
pii: ijerph18105274
doi: 10.3390/ijerph18105274
pmc: PMC8156350
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIEHS NIH HHS
ID : P30 ES023515
Pays : United States
Organisme : National Institute of Environmental Health Studies
ID : P30ES023515

Références

Lancet Infect Dis. 2020 Dec;20(12):1401-1408
pubmed: 32758438
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Ann Intern Med. 2020 Oct 20;173(8):143-144
pubmed: 32915642
Infect Control Hosp Epidemiol. 2020 Dec;41(12):1468-1469
pubmed: 32758311
JAMA. 2020 Sep 1;324(9):893-895
pubmed: 32780804
JAMA Intern Med. 2020 Dec 1;180(12):1707-1709
pubmed: 32780100
Ann Epidemiol. 2020 Aug;48:23-29.e4
pubmed: 32648546
QJM. 2020 Aug 10;:
pubmed: 32777050
Eur J Epidemiol. 2021 Feb;36(2):179-196
pubmed: 33634345
Nature. 2021 Feb;590(7844):146-150
pubmed: 33142304
Behav Res Methods. 2019 Feb;51(1):409-428
pubmed: 29869222
N Engl J Med. 2020 May 14;382(20):1957-1958
pubmed: 32243118
Sci Transl Med. 2020 Jun 3;12(546):
pubmed: 32493791
BMC Pulm Med. 2020 Jul 29;20(1):203
pubmed: 32727446
J Clin Invest. 2020 Sep 1;130(9):4726-4733
pubmed: 32463802
Infect Control Hosp Epidemiol. 2021 Apr;42(4):381-387
pubmed: 32900402
J Infect. 2021 Jan;82(1):159-198
pubmed: 32739485
Ann Intern Med. 2021 May;174(5):649-654
pubmed: 33513035
Science. 2020 Jul 17;369(6501):297-301
pubmed: 32471856
PLoS One. 2016 Dec 20;11(12):e0168546
pubmed: 27997602
JAMA. 2020 May 26;323(20):2027-2028
pubmed: 32338710
Infect Control Hosp Epidemiol. 2021 Feb;42(2):212-214
pubmed: 32746953
J Gen Intern Med. 2020 Aug;35(8):2485-2486
pubmed: 32495088
JAMA. 2010 Feb 24;303(8):747-53
pubmed: 20179284
JAMA Surg. 2020 Jul 1;155(7):624-627
pubmed: 32250417
Ann Intern Med. 2021 Jan;174(1):W18-W19
pubmed: 33226856
Surgery. 2020 Jul;168(1):11-13
pubmed: 32473830
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):472-476
pubmed: 32298249
MMWR Morb Mortal Wkly Rep. 2020 Nov 20;69(46):1725-1729
pubmed: 33211680
Fam Pract. 2021 Mar 29;38(2):76-79
pubmed: 32766704
Ann Intern Med. 2020 Jul 21;173(2):120-136
pubmed: 32369541

Auteurs

Kate R Pawloski (KR)

Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Department of Surgery, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Betty Kolod (B)

Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Rabeea F Khan (RF)

Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Vishal Midya (V)

Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Tania Chen (T)

Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Adeyemi Oduwole (A)

Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Bernard Camins (B)

Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Elena Colicino (E)

Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

I Michael Leitman (IM)

Department of Surgery, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Department of Graduate Medical Education, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Ismail Nabeel (I)

Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Kristin Oliver (K)

Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Damaskini Valvi (D)

Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH